Ligand validation:4ZAU

YY3: N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide

YY3 is a Ligand Of Interest in 4ZAU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4ZAU_YY3_A_1101	57%	10%	0.168	0.945	1.69	2.66	7	17	0	0	100%	1
6JXT_YY3_A_1101	80%	12%	0.094	0.942	2.02	2.09	10	10	2	0	100%	1
7JXP_YY3_C_1102	67%	11%	0.137	0.947	2.13	2.1	12	11	2	0	100%	1
6JX0_YY3_A_1101	67%	8%	0.127	0.934	2.17	2.47	12	16	3	0	100%	1
6LUD_YY3_A_1101	66%	67%	0.137	0.943	0.6	0.66	-	1	1	0	100%	1
6JX4_YY3_A_1101	65%	9%	0.12	0.921	2.15	2.25	11	15	0	0	100%	0.95
6JWL_YY3_A_1101	64%	10%	0.126	0.924	2.05	2.25	9	12	2	0	100%	0.9032

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.